NPI registry status
Active
2026 NPPES data Vascular Neurology Physician NPI 1033202353 MD
Verify on CMS → Matthew Tilem, MD
Vascular Neurology Physician in Burlington, Massachusetts.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 603 in Vascular Neurology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 231 beneficiaries · Vascular Neurology Physician avg: 389
Generic prescribing
85%
generic claims · 15% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.4/100
▲ 8 pts above national avg 83.5 · Exceptional
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Matthew Tilem, MD reported a CMS MIPS final score of 91.4/100 - above the 83.5 national average - and filed 1,086 Medicare Part D claims in 2024.
- 91.4/100
- MIPS score · +8 vs avg
- 1K
- Part D claims, 2024
- 85%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Matthew Tilem, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1033202353), first enumerated 09/30/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,086 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 91.4/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- State context
State board disciplinary context
Massachusetts statewide board action statistics are published annually — these figures describe aggregate state activity, not Matthew Tilem, MD's individual license status. Verify directly with the state medical board.
Source: BORIM annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1033202353 · Vascular Neurology Physician
NPI-10 · ENUM-LEGACY · TAX-NARROW · MIPS-ABOVE · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1033202353
- ENUM-LEGACY 2006
- TAX-NARROW 603
- MIPS-ABOVE 91.4/100
- RX-MID 1,086
- BOOK-THIN 19 in Massachusetts
- PHOTO-FINISH Henry Echiverri, MD · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Eric Bershad, MD…
Eric Bershad, MD
91.3 MIPS pts
- Tilem · this pro…
Tilem · this provider
91.4 MIPS pts
- Hurmina Muqtadar…
Hurmina Muqtadar, MD
91.4 MIPS pts
- Henry Echiverri,…
Henry Echiverri, MD
91.4 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Matthew Tilem, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
91 ≥ 61st percentile 61% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Matthew Tilem, MD sits
This provider among vascular neurology physician peers
Across the 137 vascular neurology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Matthew Tilem, MD writes more Part D claims than 88% of them and scores higher on MIPS quality than 64% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one vascular neurology physician peer from a representative sample of 60; the gold marker is Matthew Tilem, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Matthew Tilem, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Matthew Tilem, MD?
High performer (top quartile)Primary specialty
Vascular Neurology Physician
Medicare Part D claims
1,086 179% vs specialty avg
MIPS final score
91.4/100 7.9 pts vs avg
Specialty distribution in Massachusetts
How Vascular Neurology Physician compares to other specialties among Massachusetts providers
Medicare quality performance, MIPS
Matthew Tilem, MD's 2023 MIPS final score plotted against the Vascular Neurology Physician national average
- MIPS Final Score
- 91.4/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1033202353 |
|---|---|
| Specialty | Vascular Neurology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 09/30/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
91.4157
Final Score
Measured-score avg: 83.5
76.877
Quality
100
Promoting Interoperability
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where Matthew Tilem, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Lahey Clinic Inc
Burlington, MA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context - Massachusetts BORIM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 - they are NOT specific to Matthew Tilem, MD. To verify Matthew Tilem, MD's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases
BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Matthew Tilem, MD - brand share 15.0%
Vascular Neurology Physician average
15% brand-name claims vs 85% generic, on 1,086 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,086
Total Claims
$158K
Total Drug Cost
231
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,943.033
- Total Day Supply
- 57,319
- Brand vs Generic
- 15% brand / 85% generic
- Brand Drug Cost
- $130K
- Generic Drug Cost
- $28K
Patient Demographics
- Average Patient Age
- 74.3 years
- Avg HCC Risk Score
- 1.74
- Gender Split
- 59% female / 41% male
- Age Distribution
- <65: 25, 65-74: 76, 75-84: 95, 85+: 35
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Matthew Tilem, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Levetiracetam
Levetiracetam
94 claims
- Gabapentin
Gabapentin
84 claims
- Donepezil Hcl
Donepezil Hcl
62 claims
- Memantine Hcl
Memantine Hcl
62 claims
- Nortriptyline Hcl
Nortriptyline Hcl
59 claims
- Eliquis
Eliquis
56 claims
- Aimovig Autoinjector
Aimovig Autoinjector
55 claims
- Topiramate
Topiramate
48 claims
| Drug | Claims |
|---|---|
| Levetiracetam | 94 |
| Gabapentin | 84 |
| Donepezil Hcl | 62 |
| Memantine Hcl | 62 |
| Nortriptyline Hcl | 59 |
| Eliquis Apixaban | 56 |
| Aimovig Autoinjector Erenumab-Aooe | 55 |
| Topiramate | 48 |
| Atorvastatin Calcium | 43 |
| Rizatriptan Rizatriptan Benzoate | 34 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Vascular Neurology Physician Overview
How Matthew Tilem, MD fits within the Vascular Neurology Physician landscape nationally.
603
Vascular Neurology Physician Providers in US
47
States with Vascular Neurology Physician
389
Avg Claims per Provider
Matthew Tilem, MD's 1,086 claims are above the specialty average of 389.
Nationwide Vascular Neurology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Tilem, both outside Massachusetts so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (91.4 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Vascular Neurology Physician Providers in Massachusetts
Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as Tilem.
One of 19 Vascular Neurology Physician providers enrolled in Massachusetts, 5 are shown here.
Dr. Adel Alhazzani
M.D
Boston, MA
Dr. Hakan Ay
MD
Charlestown, MA
Dr. Metin Bicen
MD
Worcester, MA
Dr. Gustavo Carvajal
MD
Boston, MA
Dr. Anna Cervantes-Arslanian
M.D.
Boston, MA
Compare Vascular Neurology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Matthew Tilem, MD's specialty? ▼
Matthew Tilem, MD specializes in Vascular Neurology Physician and practices in Burlington, Massachusetts. Credentials: MD.
How much does Matthew Tilem, MD prescribe under Medicare Part D? ▼
In 2024, Matthew Tilem, MD wrote 1,086 Medicare Part D claims totaling $158K in drug costs for 231 beneficiaries.
What is Matthew Tilem, MD's Medicare quality score? ▼
Matthew Tilem, MD has a CMS MIPS Final Score of 91.4/100 (Quality: 76.9). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Matthew Tilem, MD located? ▼
Matthew Tilem, MD is located at LAHEY CLINIC, Burlington, MA, 01805. Phone: (781) 744-8000.
What is Matthew Tilem, MD's NPI number? ▼
Matthew Tilem, MD's National Provider Identifier (NPI) is 1033202353, issued on 09/30/2006.
Does Matthew Tilem, MD prescribe more brand-name or generic drugs? ▼
Matthew Tilem, MD's prescribing is 15% brand-name and 85% generic drugs by claim count, with $130K in brand drug costs.
How many Vascular Neurology Physician providers are there in the US? ▼
There are 603 Vascular Neurology Physician providers across 47 states in the US. The average Vascular Neurology Physician provider writes 389 Medicare Part D claims per year.
What drugs does Matthew Tilem, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Matthew Tilem, MD's most frequently prescribed drugs include Levetiracetam, Gabapentin, Donepezil Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Matthew Tilem, MD accept Medicare? ▼
Matthew Tilem, MD appears in CMS Medicare data with 1,086 Part D claims and 231 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Matthew Tilem, MD's credentials? ▼
Matthew Tilem, MD's NPI is 1033202353 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.